论文部分内容阅读
目的:探讨三联疗法治疗幽门螺杆菌感染性胃病的临床疗效。方法:选取幽门螺杆菌感染性胃病患者160例,随机分为观察组和对照组各80例。观察组患者采取蒙药三联疗法进行治疗,对照组患者采取传统三联疗法进行治疗,比较两组患者的治疗效果。结果:经过治疗,两组患者的临床症状、生命体征、幽门螺杆菌情况等表现均有不同程度的改变,且观察组总有效率为96.25%,明显优于对照组的81.25%,差异具有统计学意义(P<0.05)。结论:采取蒙药三联疗法治疗幽门螺杆菌感染性胃病疗效显著,治疗时间短,且不易复发,具有长久有效的治疗效果,值得临床推广应用。
Objective: To investigate the clinical efficacy of triple therapy in the treatment of Helicobacter pylori infection of stomach. Methods: One hundred and sixty patients with Helicobacter pylori infection gastritis were selected and randomly divided into observation group and control group with 80 cases each. Patients in the observation group were treated with Mongolian medicine triple therapy, while patients in the control group were treated with traditional triple therapy, and the therapeutic effect was compared between the two groups. Results: After treatment, the clinical symptoms, vital signs and Helicobacter pylori in both groups changed in different degrees. The total effective rate in the observation group was 96.25%, which was significantly better than that in the control group (81.25%). The difference was statistically significant Significance (P <0.05). Conclusion: The Mongolian medicine triple therapy for the treatment of Helicobacter pylori infection in stomach significant effect, short treatment time, and difficult to relapse, with long-term effective treatment, it is worth promoting the clinical application.